Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 3517209, 9 pages
http://dx.doi.org/10.1155/2016/3517209
Research Article

Morphine Antidependence of Erythroxylum cuneatum (Miq.) Kurz in Neurotransmission Processes In Vitro

1Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia
2Atta-ur-Rahman Institute for Natural Product Discovery, Aras 9 Bangunan FF3, UiTM Puncak Alam, Bandar Baru Puncak Alam, 42300 Selangor Darul Ehsan, Malaysia
3Faculty of Health Sciences, Universiti Teknologi MARA, Kampus Puncak Alam, 42300 Puncak Alam, Selangor Darul Ehsan, Malaysia

Received 1 August 2016; Revised 11 October 2016; Accepted 23 October 2016

Academic Editor: Ki-Wan Oh

Copyright © 2016 Noor Azuin Suliman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Camí and M. Farré, “Mechanisms of disease: drug addiction,” New England Journal of Medicine, vol. 349, no. 10, pp. 975–986, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. H. G. Cruz, F. Berton, M. Sollini et al., “Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice,” Journal of Neuroscience, vol. 28, no. 15, pp. 4069–4077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. T. Williams, M. J. Christie, and O. Manzoni, “Cellular and synaptic adaptations mediating opioid dependence,” Physiological Reviews, vol. 81, no. 1, pp. 299–343, 2001. View at Google Scholar · View at Scopus
  4. T. C. Süudhof, “Neurotransmitter release,” in Pharmacology of Neurotransmitter Release, pp. 1–21, Springer, Berlin, Germany, 2008. View at Google Scholar
  5. T. C. Südhof, “The synaptic vesicle cycle,” Annual Review of Neuroscience, vol. 27, pp. 509–547, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Jahn, T. Lang, and T. C. Südhof, “Membrane fusion,” Cell, vol. 112, no. 4, pp. 519–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Bu, Y. Yang, G. Yan et al., “Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention,” Journal of Proteomics, vol. 75, no. 4, pp. 1330–1342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Vekrellis, H. J. Rideout, and L. Stefanis, “Neurobiology of α-synuclein,” Molecular Neurobiology, vol. 30, no. 1, pp. 1–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Baptista, C. O'Farrell, S. Daya et al., “Co-ordinate transcriptional regulation of dopamine synthesis genes by α-synuclein in human neuroblastoma cell lines,” Journal of Neurochemistry, vol. 85, no. 4, pp. 957–968, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Wersinger and A. Sidhu, “Attenuation of dopamine transporter activity by α-synuclein,” Neuroscience Letters, vol. 340, no. 3, pp. 189–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. K. E. Larsen, Y. Schmitz, M. D. Troyer et al., “α-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis,” The Journal of Neuroscience, vol. 26, no. 46, pp. 11915–11922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Ziolkowska, A. Gieryk, W. Bilecki et al., “Regulation of α-synuclein expression in limbic and motor brain regions of morphine-treated mice,” Journal of Neuroscience, vol. 25, no. 20, pp. 4996–5003, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Martinez, I. Moeller, H. Erdjument-Bromage, P. Tempst, and B. Lauring, “Parkinson's disease-associated α-synuclein is a calmodulin substrate,” The Journal of Biological Chemistry, vol. 278, no. 19, pp. 17379–17387, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. DeLorenzo, “Calmodulin in neurotransmitter release and synaptic function,” Federation Proceedings, vol. 41, no. 7, pp. 2265–2272, 1982. View at Google Scholar · View at Scopus
  15. R. M. Evans and G. W. Zamponi, “Presynaptic Ca2+ channels—integration centers for neuronal signaling pathways,” Trends in Neurosciences, vol. 29, no. 11, pp. 617–624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. W.-Y. Lu, H.-Y. Man, W. Ju, W. S. Trimble, J. F. MacDonald, and Y. T. Wang, “Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons,” Neuron, vol. 29, no. 1, pp. 243–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Jahn and T. C. Südhof, “Membrane fusion and exocytosis,” Annual Review of Biochemistry, vol. 68, no. 1, pp. 863–911, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. C. Lin and R. H. Scheller, “Mechanisms of synaptic vesicle exocytosis,” Annual Review of Cell and Developmental Biology, vol. 16, no. 1, pp. 19–49, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. McNew, F. Parlatl, R. Fukuda et al., “Compartmental specificity of cellular membrane fusion encoded in SNARE proteins,” Nature, vol. 407, no. 6801, pp. 153–159, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Wang, X. Zeng, Y. Zhu et al., “Effects of thyroxine and donepezil on hippocampal acetylcholine content, acetylcholinesterase activity, synaptotagmin-1 and SNAP-25 expression in hypothyroid adult rats,” Molecular Medicine Reports, vol. 11, no. 2, pp. 775–782, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. Mattick, C. Breen, J. Kimber, and M. Davoli, “Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence,” Cochrane Database of Systematic Reviews, vol. 3, no. 3, Article ID CD002209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. A. Jamil, M. F. M. Subki, T. M. Lan, M. I. A. Majid, and M. I. Adenan, “The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK–N–SH neuroblastoma cell,” Journal of Ethnopharmacology, vol. 148, no. 1, pp. 135–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. K.-C. Chen, P.-H. Kao, S.-R. Lin, and L.-S. Chang, “p38 MAPK activation and mitochondrial depolarization mediate the cytotoxicity of Taiwan cobra phospholipase A2 on human neuroblastoma SK-N-SH cells,” Toxicology Letters, vol. 180, no. 1, pp. 53–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Yu, X. Mao, A. D. Blake, W. X. Li, and S. L. Chang, “Morphine and endomorphins differentially regulate μ-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 2, pp. 447–454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. E. J. Nestler and G. K. Aghajanian, “Molecular and cellular basis of addiction,” Science, vol. 278, no. 5335, pp. 58–63, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. M. S. Brown, R. G. W. Anderson, and J. L. Goldstein, “Recycling receptors: the round-trip itinerary of migrant membrane proteins,” Cell, vol. 32, no. 3, pp. 663–667, 1983. View at Publisher · View at Google Scholar · View at Scopus
  27. V. C. Yu and W. Sadée, “Efficacy and tolerance of narcotic analgesics at the Mu opioid receptor in differentiated human neuroblastoma cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 245, no. 1, pp. 350–355, 1988. View at Google Scholar · View at Scopus
  28. I. Gomes, A. Gupta, J. Filipovska, H. H. Szeto, J. E. Pintar, and L. A. Devi, “A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 5135–5139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Lotharius and P. Brundin, “Pathogenesis of Parkinson's disease: dopamine, vesicles and α-synuclein,” Nature Reviews Neuroscience, vol. 3, no. 12, pp. 932–942, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. D. F. Clayton and J. M. George, “Synucleins in synaptic plasticity and neurodegenerative disorders,” Journal of Neuroscience Research, vol. 58, no. 1, pp. 120–129, 1999. View at Google Scholar · View at Scopus
  31. B. Ziolkowska, A. Gieryk, A. Wawrzczak-Bargiela et al., “α-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice,” Neuropharmacology, vol. 54, no. 8, pp. 1239–1246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Yavich, H. Tanila, S. Vepsäläinen, and P. Jäkälä, “Role of α-synuclein in presynaptic dopamine recruitment,” Journal of Neuroscience, vol. 24, no. 49, pp. 11165–11170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. E. J. Nestler, “Historical review: molecular and cellular mechanisms of opiate and cocaine addiction,” Trends in Pharmacological Sciences, vol. 25, no. 4, pp. 210–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Pothos, P. Rada, G. P. Mark, and B. G. Hoebel, “Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment,” Brain Research, vol. 566, no. 1-2, pp. 348–350, 1991. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Goldstein and D. B. Goldstein, “XIX. Enzyme expansion theory of drug tolerance and physical dependence,” Research Publications—Association for Research in Nervous and Mental Disease, vol. 46, pp. 265–267, 1968. View at Google Scholar
  36. R. Nehmad, H. Nadler, and R. Simantov, “Effects of acute and chronic morphine treatment on calmodulin activity of rat brain,” Molecular Pharmacology, vol. 22, no. 2, pp. 389–394, 1982. View at Google Scholar · View at Scopus
  37. S. Quetglas, C. Iborra, N. Sasakawa et al., “Calmodulin and lipid binding to synaptobrevin regulates calcium‐dependent exocytosis,” The EMBO Journal, vol. 21, no. 15, pp. 3970–3979, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. N.-J. Xu, Y.-X. Yu, J.-M. Zhu et al., “Inhibition of SNAP-25 phosphorylation at Ser187 is involved in chronic morphine-induced down-regulation of SNARE complex formation,” The Journal of Biological Chemistry, vol. 279, no. 39, pp. 40601–40608, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. R. B. Sutton, D. Fasshauer, R. Jahn, and A. T. Brunger, “Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution,” Nature, vol. 395, no. 6700, pp. 347–353, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Gallwitz and R. Jahn, “The riddle of the Sec1/Munc-18 proteins-new twists added to their interactions with SNAREs,” Trends in Biochemical Sciences, vol. 28, no. 3, pp. 113–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Ludwig, Dendritic Neurotransmitter Release, Springer Science & Business Media, 2005.
  42. M. C. Van den Oever, N. A. Goriounova, K. Wan Li et al., “Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking,” Nature Neuroscience, vol. 11, no. 9, pp. 1053–1058, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. S. Bonifacino and B. S. Glick, “The mechanisms of vesicle budding and fusion,” Cell, vol. 116, no. 2, pp. 153–166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. H. N. Bhargava, “Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior,” Pharmacological Reviews, vol. 46, no. 3, pp. 293–324, 1994. View at Google Scholar · View at Scopus
  45. F. Bongianni, V. Carla', F. Moroni, and D. E. Pellegrini-Giampietro, “Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats,” British Journal of Pharmacology, vol. 88, no. 3, pp. 561–567, 1986. View at Publisher · View at Google Scholar · View at Scopus
  46. R. D. Burgoyne and A. Morgan, “Secretory granule exocytosis,” Physiological Reviews, vol. 83, no. 2, pp. 581–632, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Ansari, S. P. Ahmed, A. Kazi, and N. Karim, “Role of α-2 agonist clonidine in attenuation of hot flashes in patients with acute opioid abstinence syndrome,” Pakistan Journal of Pharmacology, vol. 22, no. 2, pp. 47–51, 2005. View at Google Scholar